Endurant Capital Management as of March 31, 2022
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 62 positions in its portfolio as reported in the March 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Invacare Corp Note 5.000%11/1 | 13.4 | $50M | 57M | 0.88 | |
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 12.2 | $46M | 102k | 451.64 | |
Centene Corporation (CNC) | 4.9 | $18M | 218k | 84.19 | |
Laboratory Corp Amer Hldgs Com New | 4.3 | $16M | 61k | 263.66 | |
Astrazeneca Sponsored Adr (AZN) | 4.2 | $16M | 240k | 66.34 | |
Orthofix Medical (OFIX) | 3.8 | $14M | 435k | 32.70 | |
Bristol Myers Squibb (BMY) | 3.8 | $14M | 195k | 73.03 | |
Humana (HUM) | 3.4 | $13M | 29k | 435.16 | |
Tenet Healthcare Corp Com New (THC) | 3.0 | $11M | 131k | 85.96 | |
Syneos Health Cl A | 2.7 | $10M | 123k | 80.95 | |
Avantor (AVTR) | 2.6 | $9.7M | 286k | 33.82 | |
Bio Rad Labs Cl A (BIO) | 2.6 | $9.7M | 17k | 563.23 | |
Invacare Corp Note 5.000%11/1 | 2.5 | $9.5M | 10M | 0.94 | |
Hologic (HOLX) | 2.5 | $9.5M | 124k | 76.82 | |
Si-bone (SIBN) | 2.5 | $9.3M | 413k | 22.60 | |
McKesson Corporation (MCK) | 2.4 | $8.9M | 29k | 306.12 | |
Cigna Corp (CI) | 1.8 | $6.9M | 29k | 239.61 | |
Aziyo Biologics Com Cl A (ELUT) | 1.8 | $6.6M | 1.1M | 5.95 | |
Edwards Lifesciences (EW) | 1.4 | $5.2M | 45k | 117.73 | |
Intuitive Surgical Com New (ISRG) | 1.4 | $5.2M | 17k | 301.71 | |
Encompass Health Corp (EHC) | 1.2 | $4.7M | 66k | 71.12 | |
Ocular Therapeutix (OCUL) | 1.2 | $4.6M | 924k | 4.95 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 1.2 | $4.5M | 2.2M | 2.06 | |
Selecta Biosciences | 1.1 | $4.2M | 3.5M | 1.23 | |
Axsome Therapeutics (AXSM) | 1.1 | $4.2M | 100k | 41.39 | |
Adapthealth Corp Common Stock (AHCO) | 1.1 | $4.0M | 248k | 16.03 | |
Insmed Com Par $.01 (INSM) | 1.0 | $3.9M | 165k | 23.50 | |
Albireo Pharma | 1.0 | $3.6M | 121k | 29.83 | |
Galapagos Nv Spon Adr (GLPG) | 0.9 | $3.2M | 52k | 62.02 | |
IDEXX Laboratories (IDXX) | 0.8 | $3.1M | 5.7k | 547.04 | |
Qiagen Nv Shs New | 0.7 | $2.7M | 56k | 49.00 | |
Premier Cl A (PINC) | 0.7 | $2.7M | 76k | 35.59 | |
Sutro Biopharma (STRO) | 0.6 | $2.4M | 297k | 8.22 | |
Mettler-Toledo International (MTD) | 0.6 | $2.4M | 1.8k | 1373.37 | |
Fate Therapeutics (FATE) | 0.6 | $2.3M | 60k | 38.77 | |
Tandem Diabetes Care Com New (TNDM) | 0.6 | $2.1M | 18k | 116.31 | |
Karuna Therapeutics Ord | 0.5 | $1.9M | 15k | 126.78 | |
10x Genomics Cl A Com (TXG) | 0.5 | $1.9M | 25k | 76.07 | |
Biohaven Pharmaceutical Holding | 0.5 | $1.8M | 15k | 118.57 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.5 | $1.8M | 7.0k | 260.96 | |
Alnylam Pharmaceuticals (ALNY) | 0.5 | $1.7M | 10k | 163.31 | |
Spdr Ser Tr S&p Biotech Call Option (XBI) | 0.4 | $1.5M | 172k | 8.98 | |
Affimed Therapeutics B V | 0.4 | $1.5M | 355k | 4.37 | |
Miragen Therapeutics (VRDN) | 0.4 | $1.5M | 83k | 18.49 | |
Global Blood Therapeutics In | 0.4 | $1.5M | 43k | 34.64 | |
Immunic (IMUX) | 0.4 | $1.5M | 131k | 11.30 | |
Argenx Se Sponsored Adr (ARGX) | 0.4 | $1.4M | 4.5k | 315.40 | |
ICU Medical, Incorporated (ICUI) | 0.4 | $1.4M | 6.1k | 222.71 | |
Arcus Biosciences Incorporated (RCUS) | 0.3 | $1.2M | 39k | 31.57 | |
Rhythm Pharmaceuticals (RYTM) | 0.3 | $1.2M | 106k | 11.52 | |
DaVita Put Option (DVA) | 0.3 | $1.1M | 10k | 113.10 | |
Molecular Templates | 0.3 | $1.1M | 314k | 3.45 | |
Caredx (CDNA) | 0.3 | $1.0M | 28k | 36.97 | |
Iovance Biotherapeutics (IOVA) | 0.3 | $1.0M | 61k | 16.65 | |
Natera (NTRA) | 0.3 | $1.0M | 25k | 40.69 | |
Kezar Life Sciences | 0.3 | $988k | 60k | 16.61 | |
Charles River Laboratories (CRL) | 0.2 | $939k | 3.3k | 283.86 | |
Praxis Precision Medicines I | 0.2 | $811k | 80k | 10.21 | |
Gossamer Bio (GOSS) | 0.2 | $596k | 69k | 8.67 | |
Dariohealth Corp Com New (DRIO) | 0.1 | $431k | 74k | 5.84 | |
Phasebio Pharmaceuticals | 0.1 | $322k | 244k | 1.32 | |
Biodesix (BDSX) | 0.1 | $221k | 131k | 1.69 |